Tania Kümpfel

Research interests

Publications

• Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

  Journal of Neurology · 2023 · 10.1007/s00415-023-11910-z

• Distinct molecular profiles of skull bone marrow in health and neurological disorders

  Cell · 2023 · 10.1016/j.cell.2023.07.009

• Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis

  Journal of Neurology · 2023 · 10.1007/s00415-023-11634-0

• Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis

  Neurology Neuroimmunology & Neuroinflammation · 2021 · 10.1212/nxi.0000000000001088

• Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders

  Neurology Neuroimmunology & Neuroinflammation · 2021 · https://doi.org/10.1212/nxi.0000000000001100

• Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients

  Journal of Neuroinflammation · 2020 · https://doi.org/10.1186/s12974-020-01824-2

• Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk

  Cell · 2018 · 10.1016/j.cell.2018.09.049

• MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

  Journal of Neuroinflammation · 2018 · https://doi.org/10.1186/s12974-018-1144-2

• Apheresis therapies for NMOSD attacks

  Neurology Neuroimmunology & Neuroinflammation · 2018 · 10.1212/nxi.0000000000000504

• Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein

  Annals of Neurology · 2018 · 10.1002/ana.25291

• Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice

  Proceedings of the National Academy of Sciences · 2017 · https://doi.org/10.1073/pnas.1711233114

• Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

  Journal of Neurology Neurosurgery & Psychiatry · 2017 · https://doi.org/10.1136/jnnp-2017-315603

• Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis

  Neurology Neuroimmunology & Neuroinflammation · 2016 · 10.1212/nxi.0000000000000257

• Features of Human CD3+CD20+ T Cells

  The Journal of Immunology · 2016 · 10.4049/jimmunol.1600089

• Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation

  Science Advances · 2016 · 10.1126/sciadv.1501678

• Histopathology and clinical course of MOG-antibody-associated encephalomyelitis

  Annals of Clinical and Translational Neurology · 2015 · 10.1002/acn3.164

• Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses

  Annals of Neurology · 2015 · 10.1002/ana.24554

• Natalizumab Use During the Third Trimester of Pregnancy

  JAMA Neurology · 2014 · 10.1001/jamaneurol.2014.209

• Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

  Journal of Neurology · 2013 · https://doi.org/10.1007/s00415-013-7169-7

• Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

  Journal of Neuroinflammation · 2012 · 10.1186/1742-2094-9-14

• Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab

  Neurology · 2011 · 10.1212/wnl.0b013e3182152881

• Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis

  Neurology · 2011 · 10.1212/wnl.0b013e318228c0b1

• Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals

  Proceedings of the National Academy of Sciences · 2009 · 10.1073/pnas.0901496106

• Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity

  Brain · 2008 · 10.1093/brain/awn077

• Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis

  Neurology · 2008 · 10.1212/01.wnl.0000327671.91357.96

• Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis

  Nature Medicine · 2008 · 10.1038/nm1714

• Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters

  Multiple Sclerosis Journal · 2002 · https://doi.org/10.1191/1352458502ms839oa

Current projects

No projects listed.